BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24696091)

  • 21. Adenosine production by human B cells and B cell-mediated suppression of activated T cells.
    Saze Z; Schuler PJ; Hong CS; Cheng D; Jackson EK; Whiteside TL
    Blood; 2013 Jul; 122(1):9-18. PubMed ID: 23678003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation: changes in expression pattern of adenosine kinase, adenosine deaminase, and 5'-nucleotidase.
    Spychala J; Mitchell BS; Barankiewicz J
    J Immunol; 1997 May; 158(10):4947-52. PubMed ID: 9144513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance.
    Robin E; Marcillac F; Raddatz E
    Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(7):R614-26. PubMed ID: 25632022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P; Barretto de Mello A; Figueiredo MS
    Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients.
    Rodríguez A; Kouegnigan L; Ferster A; Cotton F; Duez P
    Hemoglobin; 2012; 36(6):545-54. PubMed ID: 23094637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.
    Souza Vdo C; Schlemmer KB; Noal CB; Jaques JA; Zimmermann CE; Leal CA; Fleck J; Casali EA; Morsch VM; Schetinger MR; Leal DB
    Parasitol Int; 2012 Dec; 61(4):690-6. PubMed ID: 22846899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
    Brun M; Bourdoulous S; Couraud PO; Elion J; Krishnamoorthy R; Lapoumeroulie C
    Pharmacogenomics J; 2003; 3(4):215-26. PubMed ID: 12931135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.
    Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J
    J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart.
    Robin E; Sabourin J; Marcillac F; Raddatz E
    J Mol Cell Cardiol; 2013 Oct; 63():14-25. PubMed ID: 23837961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients.
    Spanevello RM; Mazzanti CM; Schmatz R; Thomé G; Bagatini M; Correa M; Rosa C; Stefanello N; Bellé LP; Moretto MB; Oliveira L; Morsch VM; Schetinger MR
    Clin Chim Acta; 2010 Feb; 411(3-4):210-4. PubMed ID: 19914228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia.
    Athanassiou G; Moutzouri A; Kourakli A; Zoumbos N
    Clin Hemorheol Microcirc; 2006; 35(1-2):291-5. PubMed ID: 16899945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over.
    Kling L; Benck U; Breedijk A; Leikeim L; Heitzmann M; Porubsky S; Krämer BK; Yard BA; Kälsch AI
    Sci Rep; 2017 Sep; 7(1):11683. PubMed ID: 28916770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of adenosine system at the onset of peritonitis.
    Nakav S; Naamani O; Chaimovitz C; Shaked G; Czeiger D; Zlotnik M; Douvdevani A
    Nephrol Dial Transplant; 2010 Mar; 25(3):931-9. PubMed ID: 19861313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
    Serra S; Horenstein AL; Vaisitti T; Brusa D; Rossi D; Laurenti L; D'Arena G; Coscia M; Tripodo C; Inghirami G; Robson SC; Gaidano G; Malavasi F; Deaglio S
    Blood; 2011 Dec; 118(23):6141-52. PubMed ID: 21998208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia.
    Yan L; Fu R; Liu H; Wang H; Liu C; Wang T; Qi W; Guan J; Li L; Shao Z
    Cell Immunol; 2015 Aug; 296(2):95-105. PubMed ID: 25906694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is chronic use of hydroxyurea safe for patients with sickle cell anemia? An account of genotoxicity and mutagenicity.
    Maia Filho PA; Pereira JF; Almeida Filho TP; Cavalcanti BC; Sousa JC; Lemes RPG
    Environ Mol Mutagen; 2019 Apr; 60(3):302-304. PubMed ID: 30525240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.